- Active Pharmaceutical Ingredients
- Varenicline tartrate
- Aprepitant, Fosapitant Intermediates
- Fosaprepitant Dimeglumine
- Vildagliptin
- Efinaconazole
- Luliconazole Intermediate
- Gadoterate Meglumine
- Succinyl Alcohol Intermediate
- Mirabillon Intermediate
- Atazanavir Intermediate
- Intermediate
- Varenicline tartrate 230615-70-0
- Aprepitant 287930-73-8
- Aprepitant 127852-28-2
- Aprepitant 287930-75-0
- Aprepitant 200000-59-5
- Aprepitant 155742-64-6
- Aprepitant 252742-72-6
- Fosaprepitant Dimeglumine 990-91-0
- Fosaprepitant Dimeglumine 265121-01-5
- Vildagliptin 207557-35-5
- Vildagliptin 702-82-9
- Efinaconazole 144230-50-2
- Efinaconazole 133775-25-4
- Efinaconazole 127000-90-2
- Gadoterate Meglumine
- Mirabegron
- Luliconazole 98873-55-3
- Luliconazole 126534-31-4
- Atazanavir sulfate
- Bortezomib 179324-87-9
- Bortezomib 114457-94-2
- Bortezomib 205393-22-2
- Brinzolamide
- Rivaroxaban Intermediate 446292-08-6
- Rivaroxaban Intermediate 446292-07-5
- Cinacalcet Hydrochloride 1005450-55-4
- Cinacalcet Hydrochloride 585-50-2
- Eletriptan Intermediate
- Indacaterol intermediate 312753-53-0
- Indacaterol intermediate 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
Popular information
Nuclear magnetic resonance imaging agent Gadobenate Dimeglumine 127000-20-8
【Catalog Number】AP8800
【CAS #】 127000-20-8
【Molecular Formula】C22H28GdN3O11 •2C7H17NO5
【Molecular Weight】 1058.16
|
Alias |
(2-),[4-carboxy-5,8,11-tris(carboxymethyl) -1-phenyl-2-oxa-5,8,11-triazatridecane-13 -Carboxy (5) -N5, N8, N1, O4, O5, O8, O11, O13] -dihydro compound 1-deoxy-1-methylamine-D-glucosyl alcohol (1: 2) |
|
Catalog Number |
AP8800 |
|
CAS # |
127000-20-8 |
|
Molecular Formula |
C22H28GdN3O11 •2C7H17NO5 |
|
Molecular Weight |
1058.16 |
|
Structural Formula |
|
|
Product Introduction CAS 27000-20-8 |
cybeme glucosamine, English name Gadobenate Dimeglumine, American Chemical Abstracts registration number cas 127000-20-8. Cymbidium glucosamine (cas 127000-20-8) is a paramagnetic contrast agent for diagnostic magnetic resonance imaging (MRI) of the liver and central nervous system. Liver: Suitable for detecting focal liver damage in patients with known or suspected primary liver cancer (eg, hepatocellular carcinoma) or metastatic cancer. Central Nervous System: Cymbidium glucosamine is also suitable for MRI enhanced examination of the brain and spine, which can enhance the detection of damage and provide more diagnostic information than unenhanced magnetic resonance imaging. |
VIWIT 沪ICP备12014533号-2
